Drug class
Peripheral vasodilator; selective 5-HT2 receptor antagonist
Mechanism of action
Selectively blocks vascular and platelet 5-hydroxytryptamine (5-HT2) receptors, reducing serotonin-mediated vasoconstriction and platelet aggregation. It may also improve tissue oxidative metabolism by supporting aerobic energy production.
General use cases
- Treatment of intermittent claudication associated with peripheral arterial disease when exercise and other non-pharmacological measures have not provided adequate symptomatic benefit, under the applicable product label and NICE guidance.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
